123 related articles for article (PubMed ID: 9103338)
1. Bioequivalence of levothyroxine preparations: industry sponsorship and academic freedom.
Eckert CH
JAMA; 1997 Apr; 277(15):1200-1. PubMed ID: 9103338
[No Abstract] [Full Text] [Related]
2. Thyroid storm.
Rennie D
JAMA; 1997 Apr; 277(15):1238-43. PubMed ID: 9103350
[No Abstract] [Full Text] [Related]
3. A cautionary tale.
Zinberg DS
Science; 1996 Jul; 273(5274):411. PubMed ID: 8677431
[No Abstract] [Full Text] [Related]
4. Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
DeGroot LJ
JAMA; 1997 Sep; 278(11):895; author reply 898-9. PubMed ID: 9302231
[No Abstract] [Full Text] [Related]
5. Release of study ends drug fracas.
Sternberg S
Sci News; 1997 Apr; 151(16):236. PubMed ID: 11655105
[No Abstract] [Full Text] [Related]
6. Sponsors lose fight to stop thyroxine study publication.
McCarthy M
Lancet; 1997 Apr; 349(9059):1149. PubMed ID: 11654726
[No Abstract] [Full Text] [Related]
7. Research suppressed for seven years by drug company.
Wise J
BMJ; 1997 Apr; 314(7088):1145. PubMed ID: 9146378
[No Abstract] [Full Text] [Related]
8. Drug firm, relenting, allows unflattering study to appear.
Altman LK
N Y Times Web; 1997 Apr; ():A1, A16. PubMed ID: 11647207
[No Abstract] [Full Text] [Related]
9. Bioequivalence of levothyroxine preparations for treatment of hypothyroidism.
Spigelman MK
JAMA; 1997 Apr; 277(15):1199-200. PubMed ID: 9103337
[No Abstract] [Full Text] [Related]
10. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
[TBL] [Abstract][Full Text] [Related]
11. Drug company 'suppressed' publication of research.
Wadman M
Nature; 1996 May; 381(6577):4. PubMed ID: 8609985
[No Abstract] [Full Text] [Related]
12. $100m payout after drug data withheld.
Wadman M
Nature; 1997 Aug; 388(6644):703. PubMed ID: 9285570
[No Abstract] [Full Text] [Related]
13. Levothyroxine bioequivalence.
Schellhase KG; Ellsworth A
J Fam Pract; 1997 Jul; 45(1):23-4. PubMed ID: 9228909
[No Abstract] [Full Text] [Related]
14. Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
Bell BM
JAMA; 1997 Sep; 278(11):896; author reply 898-9. PubMed ID: 9302234
[No Abstract] [Full Text] [Related]
15. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence.
Wartofsky L
Expert Opin Pharmacother; 2002 Jun; 3(6):727-32. PubMed ID: 12036412
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
Dreyer NA
JAMA; 1997 Sep; 278(11):897; author reply 898-9. PubMed ID: 9302237
[No Abstract] [Full Text] [Related]
17. Bioequivalence of generic preparations of levothyroxine.
Toft A
Clin Endocrinol (Oxf); 2009 Oct; 71(4):603; author reply 603-4. PubMed ID: 19508682
[No Abstract] [Full Text] [Related]
18. Interchangeability of levothyroxine preparations.
Ridgway EC
Am J Med; 1996 Feb; 100(2):245-6; author reply 246-7. PubMed ID: 8629666
[No Abstract] [Full Text] [Related]
19. Interchangeability of levothyroxine preparations.
Davies TF
Am J Med; 1996 Feb; 100(2):245; author reply 246-7. PubMed ID: 8629665
[No Abstract] [Full Text] [Related]
20. The emergence of levothyroxine as a treatment for hypothyroidism.
Hennessey JV
Endocrine; 2017 Jan; 55(1):6-18. PubMed ID: 27981511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
